← BACK TO DIRECTORY
HE
APAC
Helios Equity
India + SEA Series A/B. Fintech, healthtech, B2B. $8–25M.
HQBangalore
STAGESSeries A, Series B
PARTNERSVikram Sethi, Anjali Mehta
FOUNDER FAIRNESS SCORE
47/100
Across 27 verified term sheets
FUND SIZE (CURRENT)
$410M
Total AUM $950M
VALUE-ADD (FOUNDER-RATED)
52/100
TRACK RECORD
3 / 6
33% successful exits
DEALS IN DATABASE
27
1 written reports
BEST-KNOWN DEAL
Tatva Health · $22M Series B · 2024
SIGNATURE PUSH
Founder lock-up + reverse-vesting on key-person
SIGNATURE WIN
Strong India distribution and regulatory help
Recent flag patterns
What this firm pushes for, in their own term sheets.
AMBER
Reverse-vesting on key-person event
58%
RED
Founder lock-up (5yr)
52%
AMBER
Liquidation preference (1.25× non-participating)
38%
Founder reports
SUBMIT YOUR REPORT → Verified founder voice. 1 reports.
Founder · Series B · 2024
44/100
"Lock-up was the hard ask. Distribution help in India is genuinely strong."
Early access
Negotiating with Helios Equity?.
Upload your term sheet. We'll show you exactly where they're pushing and the counter-language to send back.
247 founders on the waitlist · Beta access starts when we launch